Treating chronic lung Aspergillus with inhaled and oral antifungals
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study tests whether a combination of inhaled liposomal amphotericin B (Ambisome) plus itraconazole works better for chronic pulmonary aspergillosis (CPA). It may help control long-term Aspergillus lung infection and symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older) with chronic pulmonary aspergillosis (CPA)
- Your diagnosis is supported by chest CT scans and lab/pathology proof of Aspergillus
- You are not known to be resistant to itraconazole (especially if your CPA is a relapse)
- You can sign consent, and you are covered by France’s Health Care Regime (Sécurité Sociale)
- If you could become pregnant: you have a negative pregnancy test and use very reliable birth control throughout the first 12 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares itraconazole taken by mouth alone versus itraconazole plus steroid pills in people who have a mix of two Aspergillus lung conditions. It aims to see which approach works better to control symptoms and lung changes caused by Aspergillus infection.
This study compares two inhaled treatments (amphotericin B vs. saline) to see which one works better as maintenance therapy for people with chronic pulmonary aspergillosis. It aims to find a convenient way to keep the infection under control after initial treatment.
This study compares two antifungal medications (itraconazole and posaconazole) to see which works better for a chronic fungal lung infection called aspergillosis. If you have this condition, taking part may help control your symptoms and improve your quality of life.
This study will use special scans to see how an inhaled antifungal medicine (amphotericin B) reaches the lungs in people with chronic pulmonary aspergillosis. The results may help doctors choose better treatments in the future.
This study looks at how chronic pulmonary aspergillosis (a long-term lung infection) affects your daily life, health, and overall well-being. By joining, you'll help researchers understand what it's like to live with this condition.
This study looks at samples from your lungs that contain Aspergillus fungus to understand why some fungi become resistant to antifungal medicines. By joining, you help researchers find better ways to treat these infections.
Hear when a new Chronic Pulmonary Aspergillosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.